Doberstein Stephen K - SEC Form 4 Insider Trading Screener

General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
20 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
S3-3-2+17+0

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2018-08-15
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerA - Grant$0.00+26,00083,258+45%+$0
D
2018-08-16
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerD - Sale to issuer$58.40-6,70183,258-7%-$391,338
2018-05-16
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerS - Sale$83.39-3,43563,959-5%-$286,445
DM
2018-04-06
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerM - OptEx$8.52+160,00067,394-173%+$1,362,400
DM
2018-04-06
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerS - Sale+OE$93.06-160,00067,394-70%-$14,890,180
2018-02-16
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerS - Sale$82.94-2,42667,394-3%-$201,212
D
2017-12-15
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerA - Grant$0.00+26,00069,820+59%+$0
D
2017-11-15
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerA - Grant$0.00+17,50043,820+66%+$0
D
2017-11-16
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerD - Sale to issuer$44.23-4,78243,820-10%-$211,508
DM
2017-11-06
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerM - OptEx$9.53+396,32331,102-109%+$3,776,958
DM
2017-11-06
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerS - Sale+OE$29.00-396,32331,102-93%-$11,493,476
D
2017-10-05
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerM - OptEx$9.53+43,67731,102-347%+$416,242
D
2017-10-05
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerS - Sale+OE$24.97-43,67731,102-58%-$1,090,615
2017-08-16
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerS - Sale$19.32-1,70131,102-5%-$32,863
2017-05-16
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerS - Sale$19.55-1,70132,803-5%-$33,255
D
2017-04-05
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerM - OptEx$9.53+100,00034,504-153%+$953,000-8-7-10
D
2017-04-05
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerS - Sale+OE$21.70-100,00034,504-74%-$2,170,000-8-7-10
2017-02-16
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerS - Sale$13.14-1,26134,504-4%-$16,570+2+3+69
D
2016-12-13
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerA - Grant$0.00+17,50035,765+96%+$0+2-2-2
2016-11-16
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerS - Sale$13.96-67018,265-4%-$9,353-3-3-7
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top